CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CNAB's Revenue Growth by Quarter and Year

United Cannabis's Revenue results by quarter and year




CNAB Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December 2.98 -0.09 0.26 0.13
III Quarter September 2.13 0.10 0.20 0.31
II Quarter June 1.86 0.16 0.25 0.09
I Quarter March 0.27 0.19 - 0.10
FY   7.24 0.36 0.71 0.63



CNAB Revenue forth quarter 2017 Y/Y Growth Comment
United Cannabis Corp in the forth quarter achieved Revenue of $ 2.98 millions compare to recorded in same quarter a year ago.

According to the results reported in the forth quarter, United Cannabis Corp achieved the best Revenue growth in Biotechnology & Drugs industry. While United Cannabis Corp' s Revenue no change of % ranks overall at the positon no. 11 in the forth quarter.




CNAB Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - 100 % 44.44 %
III Quarter September 2030 % -50 % -35.48 % -
II Quarter June 1062.5 % -36 % 177.78 % -
I Quarter March 42.11 % - - -
FY   1912.28 % -49.3 % 12.7 % -

Financial Statements
United Cannabis's forth quarter 2017 Revenue $ 2.98 millions CNAB's Income Statement
United Cannabis's forth quarter 2016 Revenue $ -0.09 millions Quarterly CNAB's Income Statement
New: More CNAB's historic Revenue Growth >>


CNAB Revenue (Quarter on Quarter Growth %)

2017
2016 2015 2014
IV Quarter December 40.1 % - 30 % -58.06 %
III Quarter September 14.52 % -37.5 % -20 % 244.44 %
II Quarter June 588.89 % -15.79 % - -10 %
I Quarter March - -26.92 % - 11.11 %
FY (Year on Year)   1912.28 % -49.3 % 12.7 % -




Revenue forth quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #4
Overall #11

Revenue Y/Y Growth Statistics
High Average Low
386.79 % 64.2 % -49.78 %
(Jun 30 2018)   (Dec 31 2017)
Revenue forth quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #4
Overall #11
Revenue Y/Y Growth Statistics
High Average Low
386.79 % 64.2 % -49.78 %
(Jun 30 2018)   (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2014, 2015, 2016, 2017

United Cannabis's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
599.21 % 59.22 % -100 %
(Jun 30 2018)  


CNAB's IV. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the IV. Quarter 2017 below company average Revenue jump of 40.1% quarter on quarter, to $ 2.98 millions.

Albeit the IV. Quarter 2017 United Cannabis's performance was beneath the average of 59.22 %, this has been still encouraging news, as the IV. Quarter expension, transcends the % surge in the IV. Quarter a year ago

Within Biotechnology & Drugs industry 5 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 55.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #17
Overall #55
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #6
Healthcare Sector #17
Overall #55
Revenue Q/Q Growth Statistics
High Average Low
599.21 % 59.22 % -100 %
(Jun 30 2018)  


CNAB's IV. Quarter Q/Q Revenue Comment
United Cannabis Corp achieved in the IV. Quarter 2017 below company average Revenue jump of 40.1% quarter on quarter, to $ 2.98 millions.

Albeit the IV. Quarter 2017 CNAB's performance was beneath the ordinary , it was still encouraging news, as the current expension, transcends the % growth in the same quarter a year ago

Within Biotechnology & Drugs industry 5 other companies have achieved higher Revenue quarter on quarter growth. While United Cannabis's Revenue growth quarter on quarter, overall rank is 55.


United Cannabis's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Revenue 12 Months Ending $ 7.24 $ 4.17 $ 2.14 $ 0.44 $ 0.36
Y / Y Revenue Growth (TTM) 1899.49 % 477.5 % 161.81 % -51.09 % -
Year on Year Revenue Growth Overall Ranking # 149 # 54 # 123 # 3166 # 150
Seqeuential Revenue Change (TTM) 73.89 % 94.99 % 386.79 % 21.14 % -49.78 %
Seq. Revenue Growth (TTM) Overall Ranking # 11 # 16 # 8 # 194 # 13




Cumulative Revenue growth Comment
With 1899.49% annual Revenue growth, United Cannabis Corp would report a record annual Revenue surge if the fiscal year would end on Dec 31 2018.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 54 to 149.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
64.2 %
-49.78 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 56
Overall # 149

Revenue TTM Y/Y Growth Statistics
High Average Low
1899.49 %
621.93 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 4
S&P 500 # 11
Cumulative Revenue growth Comment
With 1899.49% annual Revenue growth, United Cannabis Corp would report a record annual Revenue surge if the fiscal year would end on Dec 31 2018.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 54 to 149.

Revenue TTM Q/Q Growth Statistics
High Average Low
386.79 %
64.2 %
-49.78 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 1
Healthcare Sector # 56
Overall # 149

Revenue TTM Y/Y Growth Statistics
High Average Low
1899.49 %
621.93 %
-51.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 4
S&P 500 # 11




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CNAB's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CNAB's Competitors
Revenue Growth for United Cannabis's Suppliers
Revenue Growth for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons



Companies with similar Revenue surge for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2018
Petmed Express Inc -0.07 %$ -0.070 millions
Zimmer Biomet Holdings, Inc. -0.16 %$ -0.159 millions
Tg Therapeutics, Inc. -0.25 %$ -0.249 millions
Bio-rad Laboratories, Inc. -0.58 %$ -0.578 millions
Healthcare Services Group Inc -0.60 %$ -0.601 millions
Biomarin Pharmaceutical Inc -1.42 %$ -1.421 millions
Inspiremd, Inc. -1.44 %$ -1.439 millions
Prophase Labs, Inc. -1.47 %$ -1.470 millions
Meridian Bioscience Inc -1.54 %$ -1.536 millions
Capital Senior Living Corp -1.60 %$ -1.601 millions
Hca Healthcare, Inc. -1.78 %$ -1.784 millions
Bausch Health Companies Inc. -1.94 %$ -1.942 millions
Mylan N.v. -2.08 %$ -2.077 millions
Opiant Pharmaceuticals, Inc. -2.21 %$ -2.211 millions
Htg Molecular Diagnostics, Inc -2.23 %$ -2.227 millions
Invacare Corporation -2.31 %$ -2.307 millions
Gilead Sciences Inc -2.59 %$ -2.589 millions
Diversicare Healthcare Services, Inc. -3.26 %$ -3.258 millions
Encision Inc -3.33 %$ -3.326 millions
Orasure Technologies Inc -3.43 %$ -3.425 millions
Alphatec Holdings, Inc. -3.58 %$ -3.576 millions
Stereotaxis, Inc. -3.81 %$ -3.806 millions
Sophiris Bio Inc. -3.85 %$ -3.846 millions
Utah Medical Products Inc -4.36 %$ -4.362 millions
Cutera Inc -4.54 %$ -4.541 millions
Quest Diagnostics Inc -5.01 %$ -5.010 millions
Myos Rens Technology Inc. -5.10 %$ -5.096 millions
Allergan Plc -5.70 %$ -5.696 millions
American Bio Medica Corp -5.76 %$ -5.757 millions
American Shared Hospital Services -6.18 %$ -6.176 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BURG's Profile

Stock Price

BURG's Financials

Business Description

Fundamentals

Charts & Quotes

BURG's News

Suppliers

BURG's Competitors

Customers & Markets

Economic Indicators

BURG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071